EARLY STAGE TRIPLE NEGATIVE BREAST CANCER
Clinical trials for EARLY STAGE TRIPLE NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY STAGE TRIPLE NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for EARLY STAGE TRIPLE NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New breast cancer trial aims to spare heart toxicity with smart drug strategy
Disease control Not yet recruitingThis Phase 2 trial tests a new antibody drug (QL1706) combined with chemotherapy in 40 people with early triple-negative breast cancer. The treatment is tailored based on how the tumor responds after initial cycles, with the goal of avoiding certain heart-damaging drugs if possib…
Matched conditions: EARLY STAGE TRIPLE NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Blood tests may guide breast cancer treatment before surgery
Knowledge-focused Not yet recruitingThis phase 2 trial is testing whether blood tests and imaging scans can tell if chemotherapy is working in people with early-stage triple-negative breast cancer before they go to surgery. The study will enroll 200 participants who will receive a combination of chemotherapy drugs …
Matched conditions: EARLY STAGE TRIPLE NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC